Albert A. Minnick

Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with In Vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)

Carolyn Discafani, Marion L. Carroll, M. Brawner Floyd et al. · Biochemical Pharmacology · 1999 · 111 citations

Life Sciences, Medicinal Chemistry, Pharmacology +11

Mechanism of Action of the Mannopeptimycins, a Novel Class of Glycopeptide Antibiotics Active against Vancomycin-Resistant Gram-Positive Bacteria

Alexey Ruzin, Guy Singh, Anatoly Severin et al. · Antimicrobial Agents and Chemotherapy · 2004 · 93 citations · Full text

Life Sciences, Biochemistry, Microbiology +17

Modes of action and inhibitory activities of new siderophore-beta-lactam conjugates that use specific iron uptake pathways for entry into bacteria

A Brochu, Nathaniel Brochu, Thalia I. Nicas et al. · Antimicrobial Agents and Chemotherapy · 1992 · 53 citations · Full text

Life Sciences, Microbiology, Pharmacology +13

Synthesis and siderophore and antibacterial activity of N5-acetyl-N5-hydroxyl-L-ornithine derived siderophore-.beta.-lactam conjugates: iron transport mediated drug delivery

E. Kurt Dolence, Albert A. Minnick, Chia En Lin et al. · Journal of Medicinal Chemistry · 1991 · 41 citations

Pharmacy, Pharmaceutics, Pharmacology +14

N5-Acetyl-N5-hydroxy-L-ornithine-derived siderophore-carbacephalosporin .beta.-lactam conjugates: iron transport mediated drug delivery

E. Kurt Dolence, Albert A. Minnick, Marvin J. Miller · Journal of Medicinal Chemistry · 1990 · 41 citations

Pharmacy, Pharmaceutics, Pharmacology +10